The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

inseratherapeutics.com

Stage

Grant | Alive

Total Raised

$150K

Last Raised

$150K | 12 yrs ago

About Insera Therapeutics

Insera Therapeutics is a company that received a SBIR Phase I grant for a project entitled: Technology development and pre-clinical testing of a novel minimally invasive catheter-based blood clot-retrieval and clot-filtering device. Their project aims to develop the industry's first catheter-based stroke treatment device that serves both as a blood clot-retrieval as well as a clot-filtering device. Stroke is a major economic burden on the tax payer costing $65.5 billion/year. The mean lifetime healthcare cost for a stroke patient is $140,048. The first step in the treatment of acute stroke is the removal of the blood clot to restore vital blood supply to the brain. However, existing catheter-based therapies have only shown modest success in removing clots and are effective in less than two-thirds of stroke patients. In addition, these therapies can release debris into the blood stream causing further strokes. The research objective of this project is to perform pre-clinical testing of a more effective clot-retrieval device and a clot-filtering device that can make existing stroke therapies safer. The broader impacts of this research are far-reaching as the global stroke burden is staggering. Each year 780,000 strokes occur in the US and nearly 20.5 million strokes occur worldwide. This project is projected to yield important outcomes. First, the efficacy of this clot-retrieval device in removing blood clots will be confirmed. Second, the efficacy of this clot-filtering device will be confirmed in preventing release of debris during catheter-based stroke treatments thereby making these procedures safer. This public-private partnership is expected to have an important positive impact on the community by saving lives, creating jobs, and decreasing the economic burden of stroke on the tax payer.

Insera Therapeutics Headquarter Location

1560 Arcola Avenue

Sacramento, California, 95835,

United States

916-849-0945

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Insera Therapeutics Patents

Insera Therapeutics has filed 73 patents.

The 3 most popular patent topics include:

  • Vascular diseases
  • Rare diseases
  • Inflammations
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/23/2018

4/12/2022

Vascular diseases, Stroke, Hematology, Rare diseases, Inflammations

Grant

Application Date

2/23/2018

Grant Date

4/12/2022

Title

Related Topics

Vascular diseases, Stroke, Hematology, Rare diseases, Inflammations

Status

Grant

Latest Insera Therapeutics News

Ischemic Stroke Aspiration Systems Market 2029 Size, Industry Share, Growth, Trends and Top Key Players: Medtronic, Penumbra, Inc., Insera Therapeutics, Imperative Care Inc., and Others

Mar 23, 2021

Search jobs 23-Mar-2021 Ischemic Stroke Aspiration Systems Market 2029 Size, Industry Share, Growth, Trends and Top Key Players: Medtronic, Penumbra, Inc., Insera Therapeutics, Imperative Care Inc., and Others Impact of COVID-19 on the HealthcareIndustry The COVID-19 pandemic has causedsevere impacts on the global economy at various levels and which can be seen onthe Healthcare industry as well. The thriving market of health care researchand development is expected to exhibit a steep decline in the sales during thelockdown period owing to the shutdown of the manufacturing units, acuteshortage in the supply of raw materials and absence of potential manpower. Itcan be deduced from the current situations brought about by the pandemic thatthe production, and supply chain activities have experienced minor hurdles.However, the market is projected to gradually recover post-COVID-19, which willpresent attractive opportunities for sales across various regions of the worldin the following years. Future Market Insights (FMI) adopteda multidisciplinary approach during the pandemic-era to focus on the growth anddevelopment of the IschemicStroke Aspiration Systems Market . Thestudy features insights on the current growth dynamics and the major revenuereforms prevailing in the market as along with the key takeaways over theforecast. The team of analysts at Future MarketInsights are focussing on research and market study to produce different IschemicStroke Aspiration Systems Market forecasts and predictions at both national andinternational levels. They have considered several leads of informationpertaining to the industry like market figures and merger estimations to assessand produce reliable and informative insights on the Ischemic Stroke AspirationSystems Market. To remain ‘ahead’ of your competitors, Ask aQuestion >> https://www.futuremarketinsights.com/ask-question/rep-gb-9662 Key Players The writer will create content on thegeneral strategies of market players. And then will write the key players inthe market are: Medtronic, Penumbra, Inc., Insera Therapeutics, Imperative CareInc., and others Segmentation The report provides insights on the important highlights and currenttrends prevailing in the market. This helps the readers to gain a deeperunderstanding and form an unbiased opinion on the market. Numeroussegmentations have been provided for this market based on: By end user, the global ischemicstroke aspiration systems market is segmented as: Hospitals Fullin-depth analysis of the parent market The analysts at FMI are dedicated toprovide insights after extensive research and study. The study also includesestimations, projections and evaluation of the market dynamics. Importantchanges in market dynamics The report has beencreated after detailed and exhaustive studies by the analysts at FMI takingseveral factors into consideration like monetary, ecological, social,mechanical, and political status of a particular demography. They study the keydata to assess the revenue and production of manufacturers across variousregions. The report also covers an in-depth analysis ofthe key changes in market dynamics in the recent past and the near future. Segmentationdetails of the market Emerging segments and regional markets Queries Solved What is the size of the overall IschemicStroke Aspiration Systems Market in the Healthcare Industry and its segments? What are the key segments andsub-segments in the market? What are the key drivers, restraints,opportunities, and challenges of the Ischemic Stroke Aspiration Systems Marketin the Healthcare Industry, and how they are expected to impact the market? What are the attractive investmentopportunities within the Ischemic Stroke Aspiration Systems Market in theHealthcare Industry? What is the Ischemic Stroke AspirationSystems Market in the Healthcare Industry size at the regional andcountry-level? What are the key market playersfocusing on? What are the strategies for growthadopted by the key players in Ischemic Stroke Aspiration Systems Market in theHealthcare Industry? What are the recent trends in IschemicStroke Aspiration Systems Market in the Healthcare Industry? (M&A,partnerships, new product developments, expansions)? What are the challenges to the IschemicStroke Aspiration Systems Market in the growth of the Healthcare Industry? What are the key market trendsimpacting the growth of the Ischemic Stroke Aspiration Systems Market in theHealthcare Industry? To receive extensive list of importantregions, ask for TOC here >>  https://www.futuremarketinsights.com/toc/rep-gb-9662 Table of Content MarketBackground    Reasons to Buythe report We provide authentic and detailed ananalysis on various market trends to enable businesses to make informed andbeneficial decisions to attain competitive edge over key players. Our analysts provide detailed marketsegmentation along with meaningful insights and extensive reports that othercompanies fail to include. The report includes accurate analysisof the market and the current developing trends affecting the growth. FMI speaks tostakeholders across the spectrum, including C-level executives, distributors,product manufacturers, industry experts. This ensures that the data collected is fromhighly reliable sources. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Dermal Fillers Market – Diverse applications of dermal fillers in helping to improve an individual’sappeatance have been sustaining growth of the market. According to FMI, dermalfillers market is projected to exhibit 2.9% CAGR between 2021 and 2031. Electrophysiology Market – Cardiac complications are grim health concerns, reported by the World HealthOrganization (WHO) for being the leading cause of death. Various interventionalprocedures and implantable cardiac devices are instrumentallyimplemented for the management of the cardiac arrhythmias. Respiratory Devices Market – According to the World Health Organization (WHO), chronic obstructivepulmonary diseases (COPD) is a major health concern and is one of the leadingcauses of death globally. Technologically advanced medical devices andeffective drugs have become key to the management of COPD and other respiratorydisorders. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Insera Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Insera Therapeutics Rank

  • Where is Insera Therapeutics's headquarters?

    Insera Therapeutics's headquarters is located at 1560 Arcola Avenue, Sacramento.

  • What is Insera Therapeutics's latest funding round?

    Insera Therapeutics's latest funding round is Grant.

  • How much did Insera Therapeutics raise?

    Insera Therapeutics raised a total of $150K.

  • Who are the investors of Insera Therapeutics?

    Investors of Insera Therapeutics include National Science Foundation.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.